日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A highly potent and broadly accessible bispecific nanobody for the treatment of ebola virus infections

一种高效且易于获取的双特异性纳米抗体,可用于治疗埃博拉病毒感染

Bu, Fan; Ye, Gang; Morsheimer, Kimberly; Turner-Hubbard, Hailey; Eaton, Brett; Anantpadma, Manu; Bheemanapally, Khaggeswar; Tan, Chalet; Davey, Robert; Li, Fang

Single-cell image-based screens identify host regulators of Ebola virus infection dynamics.

基于单细胞图像的筛选方法可识别埃博拉病毒感染动态的宿主调控因子。

Carlson Rebecca J, Patten J J, Stefanakis George, Soong Brian Y, Radhakrishnan Adityanarayanan, Singh Avtar, Thakur Naveen, Sheehan Kathleen C F, Amarasinghe Gaya K, Hacohen Nir, Basler Christopher F, Leung Daisy W, Uhler Caroline, Davey Robert A, Blainey Paul C

A protein-proximity screen reveals Ebola virus co-opts the mRNA decapping complex through the scaffold protein EDC4

蛋白质邻近筛选揭示埃博拉病毒通过支架蛋白EDC4劫持mRNA脱帽复合物。

Donahue, Callie J; Kesari, Aditi S; Thakur, Naveen; Wang, Ling; Stubbs, Sarah Hulsey; Williams, Caroline G; Sharma, Sandhya Bharti; Kirby, Cara D; Leung, Daisy W; Aryal, Uma K; Basler, Christopher F; LaCount, Douglas J; Davey, Robert A

Ebola virus VP35 NNLNS motif modulates viral RNA synthesis and MIB2-mediated signaling

埃博拉病毒VP35 NNLNS基序调节病毒RNA合成和MIB2介导的信号传导

Uwase, Grace; Luthra, Priya; Vogel, Olivia A; Batra, Jyoti; La Rosa, Bruno A; Sheehan, Kathleen C F; Khatavkar, Oam; Payton, Jacqueline E; Davey, Robert A; Krogan, Nevan J; Basler, Christopher F; Leung, Daisy W; Amarasinghe, Gaya K

Guardians at the Gate: Optimization of Small Molecule Entry Inhibitors of Ebola and Marburg Viruses.

守门人:埃博拉病毒和马尔堡病毒小分子进入抑制剂的优化

Argade Malaika D, Achi Jazmin Galván, Bott Ryan, Morsheimer Kimberly M, Owen Callum D, Zielinski Christian A, Gaisin Arsen M, Alvarez Mario, Moore Terry W, Bu Fan, Li Fang, Cameron Michael, Anantpadma Manu, Davey Robert A, Peet Norton P, Rong Lijun, Gaisina Irina N

Operationalizing Decentralized Clinical Trials: Technology Insights from the Trials@Home RADIAL Proof-of-Concept Trial

实现分散式临床试验:来自 Trials@Home RADIAL 概念验证试验的技术启示

Hanke, Sten; Giannikopoulos, Dimitrios; Neumayer, Bernhard; Vedenkannas, Tea; Davey, Robert; Mpaltadoros, Lampros; Guthrie, Brian; Jackson, Rebecca; Lagerwaard, Bart; Zuidgeest, Mira

Recruiting and Consenting Decentralized Clinical Trial Participants-Learnings from the Trials@Home RADIAL Proof-of-Concept Trial

招募和同意分散式临床试验参与者——来自 Trials@Home RADIAL 概念验证试验的经验教训

Lagerwaard, Bart; Rutgrink, Linda; van Weelij, Danny; Lipinska, Katarzyna; Bornemann, Tina; Davey, Robert; Fons-Martinez, Jaime; Dupont, Sabine; Grobbee, Diederick E; Zuidgeest, Mira G P

Inhibition of dimeric SARS-CoV-2 Mpro displays positive cooperativity and a mixture of covalent and non-covalent binding.

二聚体 SARS-CoV-2 Mpro 的抑制表现出正协同性,并且是共价和非共价结合的混合

Padmanabha Das Krishna M, Chen Jun, Charifson Paul S, Green Jeremy, Tang Henry, Panchal Sanjay, Pu Fan, Korepanova Alla, Dubey Abhinav, Afanador Gustavo, Stojkovic Vladimir, Nocek Boguslaw, Bigelow Lance, Stubbs Sarah H, Davey Robert A, DeGoey David A, Arthanari Haribabu, Namchuk Mark N

Soluble CD4 inhibits Ebola virus infection by targeting endosomal receptor-binding site.

可溶性CD4通过靶向内体受体结合位点抑制埃博拉病毒感染

Wang Leah Liu, Keiser Patrick, Yang Derek, Seravalli Javier, Patten J J, Eaton Brett, Anderson Dirk, Liu Yi, Holbrook Michael R, Smith Amos B 3rd, Davey Robert A, Xiang Shi-Hua

Unlocking the potential of phytochemicals in inhibiting SARS-CoV-2 M(Pro) protein - an in silico and cell-based approach

利用计算机模拟和细胞方法探索植物化学物质抑制SARS-CoV-2 M(Pro)蛋白的潜力

Singh, Khushboo; Patten, J J; Dimet-Wiley, Andrea; Davey, Robert A; Watowich, Stanley J; Chandra, Amit; Leverett, Jesse